You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: June 20, 2025

Details for Patent: 10,894,028


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,894,028
Title:Methods of reducing the risk of a cardiovascular event in a subject at risk for cardiovascular disease
Abstract: In various embodiments, the present invention provides methods of reducing the risk of a cardiovascular event in a subject on statin therapy and, in particular, a method of reducing the risk of a cardiovascular event in a subject on statin therapy having a fasting baseline triglyceride level of about 135 mg/dL to about 500 mg/dL, and administering to the subject a pharmaceutical composition comprising about 1 g to about 4 g of eicosapentaenoic acid ethyl ester or a derivative thereof.
Inventor(s): Soni; Paresh (Mystic, CT)
Assignee: Amarin Pharmaceuticals Ireland Limited (Dublin, IE)
Application Number:16/775,521
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,894,028

Introduction

United States Patent 10,894,028, titled "Methods of reducing the risk of a cardiovascular event in a subject at risk for cardiovascular disease," is a patent that outlines innovative methods for mitigating cardiovascular risks. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

Publication Details

  • Publication Number: US10,894,028B2
  • Authority: United States
  • Prior Art Keywords: study, subject, patients, visit, patient
  • Legal Status: Active[4].

Scope of the Patent

The patent focuses on methods to reduce the risk of cardiovascular events in subjects who are at risk and are on statin therapy. This scope is critical in the medical field, particularly in cardiology, as it addresses a significant health concern.

Key Aspects of the Invention

  • The patent describes specific methods involving the administration of certain compounds or therapies to subjects at risk for cardiovascular disease.
  • These methods are designed to complement statin therapy, enhancing its efficacy in reducing cardiovascular events.
  • The invention is grounded in clinical studies and data that support the effectiveness of these methods[4].

Claims of the Patent

Claim Structure

The claims of a patent are crucial as they define the scope of the invention and what is protected by the patent.

  • Independent Claims: These claims stand alone and define the invention without reference to other claims. In the case of US10,894,028B2, the independent claims outline the specific methods and compositions used to reduce cardiovascular risk.
  • Dependent Claims: These claims refer back to and further limit the independent claims. They often provide additional details or variations of the invention[3].

Claim Analysis

  • The independent claims are typically broader and set the foundation for the patent's scope.
  • For example, Claim 1 might describe the general method of administering a specific compound to a subject at risk for cardiovascular disease.
  • Dependent claims might specify the dosage, timing, or additional compounds that can be used in conjunction with the primary method.

Patent Scope Metrics

Independent Claim Length and Count

Research suggests that patent scope can be measured using metrics such as independent claim length and independent claim count. These metrics can indicate the breadth and clarity of the patent claims.

  • Independent Claim Length: Longer independent claims often indicate more detailed and specific inventions, which can be associated with narrower and more enforceable patents.
  • Independent Claim Count: A higher number of independent claims can suggest a broader scope, but it also increases the complexity and potential for litigation[3].

Application to US10,894,028B2

  • Analyzing the independent claims of US10,894,028B2, we can determine if the patent has a narrow or broad scope.
  • If the independent claims are detailed and specific, it suggests a narrower scope, which is generally associated with a higher probability of grant and shorter examination process[3].

Inventorship and Ownership

Determining True Inventors

The determination of inventorship is a critical legal matter in patent law. The true and only inventors must be listed on the patent application to ensure its validity.

  • Conception and Reduction to Practice: Inventorship involves the conception of the idea and the reduction of that idea to practice. This process must be accurately documented to avoid disputes[2].

Implications for US10,894,028B2

  • Ensuring that the correct inventors are listed on US10,894,028B2 is essential to maintain the patent's enforceability.
  • Any deceptive intent or failure to include all true inventors can lead to the patent being declared invalid[2].

Patent Landscape and Trends

Current Debates on Patent Quality

There is ongoing debate about the quality of patents, with concerns over the breadth and clarity of granted patents. This debate affects the overall patent landscape.

  • Patent Quality Metrics: Metrics such as patent maintenance payments, forward citations, and the breadth of patent classes are used to assess patent quality. Narrower claims at publication are often associated with higher quality patents[3].

Impact on US10,894,028B2

  • The patent's position within this landscape is crucial. If US10,894,028B2 has narrow and clear claims, it is more likely to be considered a high-quality patent.
  • This can influence its enforceability and the likelihood of it being cited in future patents[3].

Potential for Litigation and Enforcement

Small Claims Patent Court

The concept of a small claims patent court has been discussed as a way to streamline patent litigation, particularly for smaller entities.

  • Feasibility and Structure: Studies by the Administrative Conference of the United States (ACUS) have explored the feasibility and potential structure of such a court. This could impact how patents like US10,894,028B2 are enforced in disputes[5].

Implications for US10,894,028B2

  • If a small claims patent court is established, it could provide a more accessible and cost-effective way to resolve disputes related to US10,894,028B2.
  • This would be particularly beneficial for smaller entities that may not have the resources for lengthy and expensive litigation[5].

Search and Documentation Resources

USPTO Resources

The United States Patent and Trademark Office (USPTO) provides several resources for searching and understanding patents.

  • Patent and Trademark Resource Centers (PTRCs): These centers offer local search resources and training in patent search techniques.
  • Electronic Official Gazette: This allows users to browse issued patents by classification or type of patent.
  • Common Citation Document (CCD): This consolidates prior art cited by multiple offices for a patent application, facilitating a more comprehensive search[1].

Key Takeaways

  • Scope and Claims: The patent's scope is defined by its claims, which must be specific and clear to ensure enforceability.
  • Inventorship: Correctly determining and listing the true inventors is crucial for the patent's validity.
  • Patent Quality: Metrics such as independent claim length and count can indicate the patent's quality and potential for enforcement.
  • Litigation and Enforcement: The potential for a small claims patent court could impact how disputes related to this patent are resolved.
  • Resources: Utilizing USPTO resources can aid in understanding and navigating the patent landscape.

FAQs

What is the main focus of United States Patent 10,894,028B2?

The main focus of US10,894,028B2 is on methods to reduce the risk of cardiovascular events in subjects at risk for cardiovascular disease, particularly those on statin therapy.

Why is inventorship important in patent law?

Inventorship is crucial because listing the true and only inventors ensures the patent's validity. Incorrect or deceptive listing can lead to the patent being declared invalid.

How can the scope of a patent be measured?

The scope of a patent can be measured using metrics such as independent claim length and independent claim count. These metrics help in assessing the breadth and clarity of the patent claims.

What is the significance of the Common Citation Document (CCD)?

The CCD consolidates prior art cited by multiple offices for a patent application, providing a single point of access to up-to-date citation data and facilitating a more comprehensive search.

How might a small claims patent court impact patent enforcement?

A small claims patent court could provide a more accessible and cost-effective way to resolve patent disputes, particularly beneficial for smaller entities that may not have the resources for lengthy and expensive litigation.

Sources

  1. USPTO: Search for patents - USPTO.
  2. Oregon State University: Determining Inventorship for US Patent Applications.
  3. SSRN: Patent Claims and Patent Scope.
  4. Google Patents: US10894028B2 - Methods of reducing the risk of a cardiovascular event in a subject at risk for cardiovascular disease.
  5. ACUS: U.S. Patent Small Claims Court.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,894,028

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Amarin Pharms VASCEPA icosapent ethyl CAPSULE;ORAL 202057-001 Jul 26, 2012 AB RX Yes Yes 10,894,028 ⤷  Try for Free USE OF VASCEPA AS AN ADJUNCT TO STATIN THERAPY TO REDUCE THE RISK OF MYOCARDIAL INFARCTION IN AN ADULT PATIENT WITH ELEVATED TRIGLYCERIDE LEVELS AND ESTABLISHED CV DISEASE OR DIABETES MELLITUS AND TWO OR MORE ADDITIONAL RISK FACTORS FOR CV DISEASE ⤷  Try for Free
Amarin Pharms VASCEPA icosapent ethyl CAPSULE;ORAL 202057-002 Feb 16, 2017 AB RX Yes No 10,894,028 ⤷  Try for Free USE OF VASCEPA AS AN ADJUNCT TO STATIN THERAPY TO REDUCE THE RISK OF MYOCARDIAL INFARCTION IN AN ADULT PATIENT WITH ELEVATED TRIGLYCERIDE LEVELS AND ESTABLISHED CV DISEASE OR DIABETES MELLITUS AND TWO OR MORE ADDITIONAL RISK FACTORS FOR CV DISEASE ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,894,028

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2013282394 ⤷  Try for Free
Australia 2018204499 ⤷  Try for Free
Australia 2020294210 ⤷  Try for Free
Brazil 112014032905 ⤷  Try for Free
Canada 2877514 ⤷  Try for Free
Canada 3067008 ⤷  Try for Free
Canada 3067012 ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.